Offer - Urjas Oil for just ₹ 1 X
Nodon 5 Tablet (10), a prescription drug, is manufactured in various forms such as Tablet. High BP are some of its major therapeutic uses.
The right dosage of Nodon 5 Tablet (10) depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Nodon 5 Tablet (10) side effects, there are can be others also. These have been listed below. Normally, these side effects of Nodon 5 Tablet (10) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Nodon 5 Tablet (10) has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Nodon 5 Tablet (10)'s effects on the liver, heart and kidney, if any, have been listed below.
Nodon 5 Tablet (10) is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. Other conditions have been mentioned below in the Nodon 5 Tablet (10) contraindications section.
Additionally, Nodon 5 Tablet (10) may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Nodon 5 Tablet (10) is considered not safe while driving, and is not addictive.
Nodon 5 Tablet (10) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nodon 5 Tablet (10) safe for pregnant women?
Nodon has many dangerous side effects in pregnant women. If you are pregnant, do not consume Nodon without medical advice.
Is the use of Nodon 5 Tablet (10) safe during breastfeeding?
Nodon should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Nodon 5 Tablet (10) on the Kidneys?
Very few cases of side effects of Nodon on kidney have been reported.
What is the effect of Nodon 5 Tablet (10) on the Liver?
Very few cases of side effects of Nodon on the liver have been reported.
What is the effect of Nodon 5 Tablet (10) on the Heart?
Side effects of Nodon rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Nodon 5 Tablet (10) unless your doctor advises you to do so -
Is this Nodon 5 Tablet (10) habit forming or addictive?
Forming a habit of Nodon 5 Tablet (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nodon 5 Tablet (10) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Nodon 5 Tablet (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Nodon 5 Tablet (10) for mental disorders.
Interaction between Food and Nodon 5 Tablet (10)
When consumed with certain foods, Nodon 5 Tablet (10) may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Nodon 5 Tablet (10)
Consumption of alcohol and Nodon 5 Tablet (10) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897